Abstract
γ-Synuclein, also referred to as breast-cancer-specific gene 1, is the third member of the neuronal protein family synuclein. Synucleins attracted the attention of many investigators because of their role in human diseases. γ-Synuclein participates in the pathogenesis of several types of cancer and some neurodegenerative diseases. Its role in tumorigenesis is due to the upregulation of transcription and the effect on downstream targets, including signaling pathways and transcription factors. γ-Synuclein is also expressed in neurons and glial cells, but the regulation of its expression, as well as the mechanism of transition from normal functions to pathology in these cell types, is not studied. Here, we examined how γ-synuclein promoter is regulated in neuronal and glial cells. We also show that γ-synuclein is able to bind directly to several transcription factors. These results are discussed in connection with the implication of γ-synuclein in diseases.
References
Benko, S., Love, J. D., Beládi, M., Schwabe, J. W. R., & Nagy, L. (2003). Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor. Journal of Biological Chemistry, 278, 43797–43806.
Bruening, W., Giasson, B., Klein-Szanto, J., Lee, V., Trojanowski, J., & Godwin, A. (2000). Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer, 88, 2154–2163.
Buchman, V. L., Hunter, H. J., Pinõn, L. G., et al. (1998). Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. Journal Neuroscience, 18, 9335–9341.
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999). Axon pathology in Parkinson’s disease and Lewy body dementia hippocampus contains a-, b-, and γ-synuclein. Proceedings of National Academy of Sciences of the United States of America, 96, 13450–13455.
Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2000). Neurodegeneration with brain iron accumulation, type 1 is characterized by a-, b-, and γ-synuclein neuropathology. American Journal of Pathology, 157, 361–368.
George, J. M. (2002). The synucleins. Genome Biology, 3, 1–6.
Goodbourn, S., & Maniatis, T. (1988). Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proceedings of National Academy of Sciences of the United States of America, 85, 1447–1451.
Ji, H., Liu, Y., Jia, T., et al. (1997). Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Research, 57, 759–764.
Jiang, Y. F., Liu, Y. E., Lu, A., et al. (2003). Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Research, 63, 3899–3903.
Jiang, Y. F., Liu, Y. A., Goldberg, I. D., & Shi, Y. E. (2004). γ-Synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Research, 64, 4539–4546.
Larose, M., Cassard-Doulcier, A. M., Fleury, C., et al. (1996). Essential cis-acting elements in rat uncoupling protein gene are in an enhancer containing a complex retinoic acid response domain. Journal of Biological Chemistry, 271, 31533–31542.
Leung, T., Bischof, J., Söll, I., et al. (2003). Bozozok directly represses bmp2b transcription and mediates the earliest dorsoventral asymmetry of bmp2b expression in zebrafish. Development, 130, 3639–3649.
Liu, J., Spence, M. J., Zhang, Y. L., Jiang, Y., Liu, Y., & Shi, Y. (2000). Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Research and Treatment, 62, 99–107.
Li, J. Y., Henning Jensen, P., & Dahlström, A. (2002). Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience, 113, 463–478.
Lu, A., Gupta, A., Li, C., et al. (2001). Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene, 20, 5173–5185.
Lu, A., Zhang, F., Gupta, A., & Liu, J. (2002). Blockade of AP1 transactivation abrogates the abnormal expression of the breast cancer-specific gene 1 in breast cancer cells. Journal of Biological Chemistry, 277, 31364–31372.
Surgucheva, I., McMahan, B., Ahmed, F., Tomarev, S., Wax, M. B., & Surguchov, A. (2002). Synucleins in glaucoma: Implication of gamma-synuclein in glaucomatous alterations in the optic nerve. Journal of Neuroscience Research, 68, 97–106.
Surgucheva, I. G., Sivak, J. M., Fini, M. E., Palazzo, R. E., & Surguchov, A. P. (2003). Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Archives of Biochemistry and Biophysics, 410, 167.
Surgucheva, I., McMahon, B., & Surguchov, A. (2006). Gamma-synuclein has a dynamic intracellular localization. Cell Motility and the Cytoskeleton, 63, 447–458.
Surguchov, A., Palazzo, R. E., & Surgucheva, I. (2001). Gamma synuclein: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motility and the Cytoskeleton, 49, 218–228.
Teelt-Hansen, J., Yano, S., Bandyopadhyay, S., Carroll, R., Brown, E. N., & Chattopadhyay, N. (2004). Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells. Endocrinology, 145, 4222–4231.
Varghese, S., Rydziel, S., & Canalis, E. (2005). Bone morphogenetic protein-2 suppresses collagenese-3 promoter activity in osteoblasts through a runt domain factor 2 binding site. Journal of Cellular Physiology, 202, 391–399.
Wu, K., Weng, Z., Tao, Q., et al. (2003). Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiology, Biomarkers and Prevention.12, 920–925.
Acknowledgments
The authors would like to thank Neeraj Agarwal (University of North Texas Health Science Center, Fort Worth, TX, USA) for RGC-5 cells and Dr. H. Geller (Department of Pharmacology Robert Wood Johnson Medical School) for the culture of A7 astrocytes. This work is supported by NIH grant EY 02687, VA Merit Review grant, and The Glaucoma Foundation grant QB42308. The technical help of Ms. Kristin Cain is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Surgucheva, I., Surguchov, A. γ-Synuclein: Cell-Type-Specific Promoter Activity and Binding to Transcription Factors. J Mol Neurosci 35, 267–271 (2008). https://doi.org/10.1007/s12031-008-9074-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9074-6